Homoveratrylamine → 2-(1,3-benzodioxol-5-yl)-N-[2-(3,4-dimethoxyphenyl)ethyl]acetamide
반응식
[CH3:1][O:2][C:3]1[CH:4]=[C:5]([CH2:11][CH2:12][NH2:13])[CH:6]=[CH:7][C:8]=1[O:9][CH3:10].[CH2:14]1[O:22][C:21]2[CH:20]=[CH:19][C:18]([CH2:23][C:24](O)=[O:25])=[CH:17][C:16]=2[O:15]1>>[CH3:1][O:2][C:3]1[CH:4]=[C:5]([CH2:11][CH2:12][NH:13][C:24](=[O:25])[CH2:23][C:18]2[CH:19]=[CH:20][C:21]3[O:22][CH2:14][O:15][C:16]=3[CH:17]=2)[CH:6]=[CH:7][C:8]=1[O:9][CH3:10]참가 물질
3
실험 절차
prepared by reaction of 3,4-dimethoxyphenylethylamine and 3,4-methylenedioxyphenylacetic acid.
출처 및 근거
- ORD 기록
- ord-c3e8b50130504d9eb677594a1e4b1814
- 출처 데이터셋
- uspto-grants-2004_03
- 특허 번호
- US06703392B2
반응 노트
불러오는 중…